List of Tables
    Table 1. Commercializing Biomarkers CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Commercializing Biomarkers Market Trends
    Table 3. Commercializing Biomarkers Market Drivers
    Table 4. Commercializing Biomarkers Market Challenges
    Table 5. Commercializing Biomarkers Market Restraints
    Table 6. Global Commercializing Biomarkers Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Commercializing Biomarkers Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Commercializing Biomarkers Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Commercializing Biomarkers Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Commercializing Biomarkers Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Commercializing Biomarkers Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Commercializing Biomarkers Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Commercializing Biomarkers Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Commercializing Biomarkers Sales Share by Manufacturer, 2017-2022
    Table 15. Global Commercializing Biomarkers Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Commercializing Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Commercializing Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercializing Biomarkers as of 2021)
    Table 18. Top Players of Commercializing Biomarkers in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Commercializing Biomarkers Product Type
    Table 20. Date of International Manufacturers Enter into Commercializing Biomarkers Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Commercializing Biomarkers Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Commercializing Biomarkers Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Commercializing Biomarkers Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Commercializing Biomarkers Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Commercializing Biomarkers Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Commercializing Biomarkers Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Commercializing Biomarkers Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Commercializing Biomarkers Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Commercializing Biomarkers Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Commercializing Biomarkers Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Commercializing Biomarkers Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Commercializing Biomarkers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Commercializing Biomarkers Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Commercializing Biomarkers Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Commercializing Biomarkers Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Commercializing Biomarkers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Commercializing Biomarkers Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Commercializing Biomarkers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Commercializing Biomarkers Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Commercializing Biomarkers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Roche Corporation Information
    Table 43. Roche Description and Business Overview
    Table 44. Roche Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Roche Commercializing Biomarkers Product
    Table 46. Roche Recent Development
    Table 47. Dako (Agilent Technologies) Corporation Information
    Table 48. Dako (Agilent Technologies) Description and Business Overview
    Table 49. Dako (Agilent Technologies) Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Dako (Agilent Technologies) Product
    Table 51. Dako (Agilent Technologies) Recent Development
    Table 52. Merck Corporation Information
    Table 53. Merck Description and Business Overview
    Table 54. Merck Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Merck Product
    Table 56. Merck Recent Development
    Table 57. BD Corporation Information
    Table 58. BD Description and Business Overview
    Table 59. BD Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. BD Product
    Table 61. BD Recent Development
    Table 62. Abbott Corporation Information
    Table 63. Abbott Description and Business Overview
    Table 64. Abbott Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Abbott Product
    Table 66. Abbott Recent Development
    Table 67. Genesys Biolabs (20/20GeneSystems) Corporation Information
    Table 68. Genesys Biolabs (20/20GeneSystems) Description and Business Overview
    Table 69. Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Genesys Biolabs (20/20GeneSystems) Product
    Table 71. Genesys Biolabs (20/20GeneSystems) Recent Development
    Table 72. Affymetrix Corporation Information
    Table 73. Affymetrix Description and Business Overview
    Table 74. Affymetrix Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Affymetrix Product
    Table 76. Affymetrix Recent Development
    Table 77. Agendia Corporation Information
    Table 78. Agendia Description and Business Overview
    Table 79. Agendia Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Agendia Product
    Table 81. Agendia Recent Development
    Table 82. ALMAC Corporation Information
    Table 83. ALMAC Description and Business Overview
    Table 84. ALMAC Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. ALMAC Product
    Table 86. ALMAC Recent Development
    Table 87. Arrayit Corporation Information
    Table 88. Arrayit Description and Business Overview
    Table 89. Arrayit Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Arrayit Product
    Table 91. Arrayit Recent Development
    Table 92. Biocartic Corporation Information
    Table 93. Biocartic Description and Business Overview
    Table 94. Biocartic Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. Biocartic Product
    Table 96. Biocartic Recent Development
    Table 97. BG Medicine Corporation Information
    Table 98. BG Medicine Description and Business Overview
    Table 99. BG Medicine Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. BG Medicine Product
    Table 101. BG Medicine Recent Development
    Table 102. KEGG EXPRESSION Database Corporation Information
    Table 103. KEGG EXPRESSION Database Description and Business Overview
    Table 104. KEGG EXPRESSION Database Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 105. KEGG EXPRESSION Database Product
    Table 106. KEGG EXPRESSION Database Recent Development
    Table 107. Thermo Fisher Corporation Information
    Table 108. Thermo Fisher Description and Business Overview
    Table 109. Thermo Fisher Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Thermo Fisher Product
    Table 111. Thermo Fisher Recent Development
    Table 112. BGI Corporation Information
    Table 113. BGI Description and Business Overview
    Table 114. BGI Commercializing Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. BGI Product
    Table 116. BGI Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Commercializing Biomarkers Customers List
    Table 120. Commercializing Biomarkers Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Commercializing Biomarkers Product Picture
    Figure 2. Global Commercializing Biomarkers Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Commercializing Biomarkers Market Size 2017-2028 (US$ Million)
    Figure 4. Global Commercializing Biomarkers Sales 2017-2028 (K MT)
    Figure 5. United States Commercializing Biomarkers Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Commercializing Biomarkers Market Size 2017-2028 (US$ Million)
    Figure 7. United States Commercializing Biomarkers Sales 2017-2028 (K MT)
    Figure 8. United States Commercializing Biomarkers Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Commercializing Biomarkers Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Commercializing Biomarkers Report Years Considered
    Figure 11. Product Picture of Consumables
    Figure 12. Product Picture of Services
    Figure 13. Product Picture of Software
    Figure 14. Global Commercializing Biomarkers Market Share by Type in 2022 & 2028
    Figure 15. Global Commercializing Biomarkers Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Commercializing Biomarkers Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Commercializing Biomarkers Sales by Type (2017-2028) & (K MT)
    Figure 18. Global Commercializing Biomarkers Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Commercializing Biomarkers Price by Type (2017-2028) & (USD/MT)
    Figure 20. United States Commercializing Biomarkers Market Share by Type in 2022 & 2028
    Figure 21. United States Commercializing Biomarkers Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Commercializing Biomarkers Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Commercializing Biomarkers Sales by Type (2017-2028) & (K MT)
    Figure 24. United States Commercializing Biomarkers Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Commercializing Biomarkers Price by Type (2017-2028) & (USD/MT)
    Figure 26. Product Picture of Oncology
    Figure 27. Product Picture of Cardiology
    Figure 28. Product Picture of Neurology
    Figure 29. Product Picture of Others
    Figure 30. Global Commercializing Biomarkers Market Share by Application in 2022 & 2028
    Figure 31. Global Commercializing Biomarkers Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Commercializing Biomarkers Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Commercializing Biomarkers Sales by Application (2017-2028) & (K MT)
    Figure 34. Global Commercializing Biomarkers Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Commercializing Biomarkers Price by Application (2017-2028) & (USD/MT)
    Figure 36. United States Commercializing Biomarkers Market Share by Application in 2022 & 2028
    Figure 37. United States Commercializing Biomarkers Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Commercializing Biomarkers Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Commercializing Biomarkers Sales by Application (2017-2028) & (K MT)
    Figure 40. United States Commercializing Biomarkers Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Commercializing Biomarkers Price by Application (2017-2028) & (USD/MT)
    Figure 42. North America Commercializing Biomarkers Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 43. North America Commercializing Biomarkers Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Commercializing Biomarkers Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 47. Europe Commercializing Biomarkers Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Commercializing Biomarkers Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 54. Asia-Pacific Commercializing Biomarkers Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Commercializing Biomarkers Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 66. Latin America Commercializing Biomarkers Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Commercializing Biomarkers Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 71. Middle East & Africa Commercializing Biomarkers Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Commercializing Biomarkers Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Commercializing Biomarkers Value Chain
    Figure 76. Commercializing Biomarkers Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed